The roles of histone deacetylases and their inhibitors in cancer therapy

G Li, Y Tian, WG Zhu - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Genetic mutations and abnormal gene regulation are key mechanisms underlying
tumorigenesis. Nucleosomes, which consist of DNA wrapped around histone cores …

Dual-target inhibitors based on HDACs: novel antitumor agents for cancer therapy

T Liu, Y Wan, Y Xiao, C Xia, G Duan - Journal of medicinal …, 2020 - ACS Publications
Histone deacetylases (HDACs) play an important role in regulating target gene expression.
They have been highlighted as a novel category of anticancer targets, and their inhibition …

p63 is a cereblon substrate involved in thalidomide teratogenicity

T Asatsuma-Okumura, H Ando, M De Simone… - Nature chemical …, 2019 - nature.com
Cereblon (CRBN) is a primary target of thalidomide and mediates its multiple
pharmacological activities, including teratogenic and antimyeloma activities. CRBN …

Structural diversity of p63 and p73 isoforms

C Osterburg, V Dötsch - Cell death & differentiation, 2022 - nature.com
The p53 protein family is the most studied protein family of all. Sequence analysis and
structure determination have revealed a high similarity of crucial domains between p53, p63 …

Molecular mechanisms of p63-mediated squamous cancer pathogenesis

MA Moses, AL George, N Sakakibara… - International journal of …, 2019 - mdpi.com
The p63 gene is a member of the p53/p63/p73 family of transcription factors and plays a
critical role in development and homeostasis of squamous epithelium. p63 is transcribed as …

Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2

H Zhang, C Fillmore Brainson, S Koyama… - Nature …, 2017 - nature.com
Adenosquamous lung tumours, which are extremely poor prognosis, may result from cellular
plasticity. Here, we demonstrate lineage switching of KRAS+ lung adenocarcinomas (ADC) …

[HTML][HTML] HDAC2 as a target for developing anti-cancer drugs

H Jo, K Shim, HU Kim, HS Jung, D Jeoung - Computational and Structural …, 2023 - Elsevier
Histone deacetylases (HDACs) deacetylate histones H3 and H4. An imbalance between
histone acetylation and deacetylation can lead to various diseases. HDAC2 is present in the …

[HTML][HTML] HDACs and the epigenetic plasticity of cancer cells: Target the complexity

C Brancolini, T Gagliano, M Minisini - Pharmacology & therapeutics, 2022 - Elsevier
Cancer cells must adapt to the hostile conditions of the microenvironment in terms of
nutrition, space, and immune system attack. Mutations of DNA are the drivers of the …

How do tumor cells respond to HDAC inhibition?

A Newbold, KJ Falkenberg, HM Prince… - The FEBS …, 2016 - Wiley Online Library
It is now well recognized that mutations, deregulated expression, and aberrant recruitment of
epigenetic readers, writers, and erasers are fundamentally important processes in the onset …

Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression

L Chen, T Wei, X Si, Q Wang, Y Li, Y Leng… - Journal of Biological …, 2013 - ASBMB
The lysine acetyltransferases play crucial but complex roles in cancer development. GCN5
is a lysine acetyltransferase that generally regulates gene expression, but its role in cancer …